44.40840 USD
0.8312
1.84%
Last update Dec 18, 3:43 PM GMT
Market closed
Day range
42.72770
46.47130
Previous close
45.23960
Open
44.75
Access this stock data via API
Subscribe
Nektar Therapeutics Inc.
44.41
0.83
1.84%

Financials

Income statement

Fundamentals currency is CAD
Fiscal date 2021 2020 2019 2018
Total reported revenue 335.6M 139.5M 205.3M 230.4M
Cost of revenue 96.3M 77.5M 90.5M 92.5M
Gross profit 239.3M 61.9M 114.7M 137.9M
Operating expense
Research & development
Selling general and admin 51.0M 39.9M 40.2M 38.1M
Other operating expenses 47.2M 48.7M 54.4M 60.3M
Operating income 141.1M -26.7M 20.2M 39.5M
Non operating interest income
Income
Expense 23.5M 22.3M 23.5M 22.2M
Other income expense 138.7M -206.8M 17.2M 6.9M
Pretax income 255.3M -256.7M 12.8M 23.2M
Tax provision 50.0M -53.6M 765K 10.4M
Net income 205.3M -203.2M 12.1M 12.8M
Basic EPS 1.3 -1.3 0.1 0.1
Diluted EPS 1.3 -1.3 0.1 0.1
Basic average shares 153.0M 152.1M 151.9M 151.1M
Diluted average shares 153.0M 152.1M 151.9M 151.1M
EBITDA 214.8M 44.5M 95.0M 115.8M
Net income from continuing op. 205.3M -203.2M 12.1M 12.8M
Minority interests
Preferred stock dividends
Access /income_statement data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 11 hours 4 minutes

20:10
00:00
08:00
16:30
23:59

Trading Hours (Monday - Friday):

Pre-market
07:15 - 08:00
Main market
08:00 - 16:30
Post-market
16:30 - 17:15
All times are displayed in the Europe/London timezone (GMT, UTC+00:00).